FOLD FY 2010 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$922,000-98.6% YoY

Gross Profit

$922,000100.0% margin

Operating Income

-$56M-6056.2% margin

Net Income

-$55M-5958.4% margin

EPS (Diluted)

$-1.98

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$113M

Total Liabilities

$48M

Stockholders' Equity

$65M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$922,000	$64M	-98.6%
Gross Profit	$922,000	$64M	-98.6%
Operating Income	-$56M	-$7M	-659.7%
Net Income	-$55M	-$7M	-736.5%